PEP/NEWS — Peptide intel. Daily.

In this edition of The Random Show, Tim Ferriss and Kevin Rose reunite over tequila to talk Zen retreats, learning to rock climb at (almost) 50, mortality and grief, why you should stop saying "one day," AI predictions , and much more. Plea

In this ⁠Huberman Lab Essentials⁠ episode, I explain the biology, symptoms and types of bipolar disorder (sometimes called bipolar depression), a condition characterized by extreme, maladaptive shifts in energy, mood and perception. I descr

🎯 Vaginal rejuvenation isn't about making tissue younger—it's about helping tissue function better. Modern vaginal rejuvenation treatments use controlled heat and energy to stimulate your body's natural repair response, improving blood fl

I'm fascinated by how Muse cells can detect injury signals and naturally travel to damaged tissue, making them one of the most exciting areas in regenerative medicine. In this video, I explain the science behind the S1P/S1PR2 signaling path

Attia's latest AMA tackles one of the loudest concerns around GLP-1 receptor agonists like semaglutide: lean muscle loss during weight reduction. His read of new data is that patients who hit protein targets and train with resistance lose very little muscle — the drug is not the problem.

Restricting food to an 8-hour window extended median lifespan by 12% in male mice. Researchers flag a key caveat: the mice also ate less overall, so it may be caloric restriction doing the work, not meal timing alone.

Forever Healthy opened Evipedia — its longevity-focused evidence database — to AI agents and research pipelines via a new API. The move could accelerate how fast researchers surface and cross-reference intervention data.

New research maps out multiple biological pathways connecting sarcopenia (age-related muscle loss) and osteoporosis (bone loss). The shared mechanisms suggest that interventions targeting muscle — including anabolic peptides — may offer downstream bone benefits.

Researchers used spatial mapping to locate senescent and disease-linked microglia — the brain's immune cells — in aged mouse brain tissue. They then tested senolytic drugs to selectively clear those cells, pointing toward a targetable mechanism in brain aging.

Nature Aging reports that aging blood stem cells develop a form of immune memory — called trained immunity — that biases the immune system toward persistent, low-grade inflammation. The finding draws a direct line between stem cell aging and the inflammatory environment that accelerates broader tissue decline.

Trained human muscle shows delayed molecular aging and better energy metabolism compared to untrained muscle. But a parallel Nature Aging study found that some age-related molecular changes accumulate regardless of exercise — meaning physical training is necessary but not sufficient.

Neurologist Gayatri Devi joins Attia to argue that early diagnosis is now genuinely actionable — not just a prognostic exercise. The episode covers new biomarkers, personalized treatment strategies, and how the window for intervention is widening.

A new open-access paper argues that therapeutic plasma exchange — replacing aged blood factors with fresh ones — and partial epigenetic reprogramming attack aging through different but complementary routes. The authors make a case for combining both approaches in future trials.